Skip to content
Invitrocue - Transforming bioanalytics
  • Home
  • About Us
    • Meet Invitrocue
    • Our Team
    • Partners
    • Corporate Governance
    • Careers
  • Oncology
    • Onco-PDO™
    • Patient FAQ
    • Physician FAQ
  • Preclinical Services
    • Overview
    • Drug Metabolism and Pharmacokinetics
    • Toxicology and Safety Assessment
    • Hepatocytes
    • 3D Cell Culture
    • Patient-derived Organoid (PDO)
    • Immunomodulatory Assays
    • Customized Assays and Disease Modelling
    • Invivocue – Humanized Mice
  • Shareholders
    • Reports
      • Financial Reports
      • Analyst Reports
    • Announcements
    • Contact Management
  • News & Resources
    • Publications
    • Conferences & Events
    • Press Releases
    • Privacy Policy
  • Contact Us
  • English
    • English
    • Deutsch
    • Español
    • Português
    • 中文 (中国)
    • 中文 (香港)
  • Home
  • About Us
    • Meet Invitrocue
    • Our Team
    • Partners
    • Corporate Governance
    • Careers
  • Oncology
    • Onco-PDO™
    • Patient FAQ
    • Physician FAQ
  • Preclinical Services
    • Overview
    • Drug Metabolism and Pharmacokinetics
    • Toxicology and Safety Assessment
    • Hepatocytes
    • 3D Cell Culture
    • Patient-derived Organoid (PDO)
    • Immunomodulatory Assays
    • Customized Assays and Disease Modelling
    • Invivocue – Humanized Mice
  • Shareholders
    • Reports
      • Financial Reports
      • Analyst Reports
    • Announcements
    • Contact Management
  • News & Resources
    • Publications
    • Conferences & Events
    • Press Releases
    • Privacy Policy
  • Contact Us
  • English
    • English
    • Deutsch
    • Español
    • Português
    • 中文 (中国)
    • 中文 (香港)

News

Investor Presentation

February 23, 2018

Investor presentation

Categories ASX Announcements, News

Change of Director's Interest Notice – Jamie Khoo

February 20, 2018

Change of Director’s Interest Notice – Jamie Khoo

Categories ASX Announcements, News

Change of Director's Interest Notice – Steven Fang

February 20, 2018

Change of Director’s Interest Notice – Steven Fang

Categories ASX Announcements, News

Change of Director's Interest Notice

February 14, 2018

Change of Director’s Interest Notice

Categories ASX Announcements, News

Change of Director's Interest Notice

February 14, 2018

Change of Director’s Interest Notice

Categories ASX Announcements, News

Change of Director's Interest Notice

February 14, 2018

Change of Director’s Interest Notice

Categories ASX Announcements, News

Change of Director's Interest Notice

February 14, 2018

Change of Director’s Interest Notice

Categories ASX Announcements, News

Change of Director's Interest Notice

February 14, 2018

Change of Director’s Interest Notice

Categories ASX Announcements, News

IVQ successfully grows liver cancer organoids

January 18, 2018

Invitrocue further validates its Onco-PDO technology platform through the successful growth of 14 liver cancer organoids

Categories ASX Announcements, News, Press Releases

IVQ receives award from Singapore government IP office

August 29, 2017

IVQ receives award from Singapore government IP office

Categories ASX Announcements, News, Press Releases
Post navigation
Older posts
Newer posts
← Previous Page1 … Page3 Page4 Page5 … Page8 Next →

Recent Posts

  • Strategic partnership & Financial advisor appointment
  • Invitrocue announces acquisition of Welala to create life science leadership in Thailand and Asean
  • Invitrocue’s Onco-PDO test is Singapore’s and world’s first validated and approved Clinical Cancer Drug Screening service for Personalised Oncology
  • Operational Updates – February 2024
  • Operational Updates – October 2023

GET IN TOUCH

51 Science Park Road, #01-11/13 The Aries, Singapore Science Park II Singapore 117586

GENERAL / PHARMACOLOGY ENQUIRIES:

+65 6460 0497
contact@invitrocue.com

ONCO-PDO ENQUIRIES:

+65 6819 0181
onco-pdo@invitrocue.com
SAC - SINGLAS Accredited Laboratory

SERVICES

Home
About Us
Oncology
Preclinical Services
Investors
News & Resources
Contact Us

Logo Invitrocue
Icon-twitter-x Facebook-f Linkedin-in Youtube

© Copyright 2026 Invitrocue. All rights reserved
Impressum | Privacy Policy | Cookies Policy | Cookie Settings